インドの血液ガス分析装置市場 – 2030 年までの業界動向と予測

インドの血液ガス分析装置市場の分析と洞察

業界における血液分析への先進技術の導入は、製品品質の向上と製造コストの削減を同時に実現するという要求、つまり競争力を確保するという要求によって促進されてきました。その結果、医療における血液ガス分析装置の需要の高まりが、予測期間中の市場成長を牽引すると考えられます。

心臓血管や神経などの慢性疾患の発生率の上昇により、市場の成長が加速しています。

インドの血液ガス分析装置市場は、2022年の5,108万米ドルから2030年には8,851万米ドルに達し、2023年から2030年の予測期間に7.1%のCAGRで成長すると予想されています。

市場の定義

「血液ガス分析」（BGA）という用語は、患者の酸素バランスと酸素状態に関連する臨床検査に使用されます。酸素状態は、O2 の分圧（pO2）とヘモグロビン酸素飽和度（sO2）を使用して測定されます。

O2 の分圧 (pO2) はアンペロメトリーで測定され、SO2 の分圧は共酸素測定法で測定されます。共酸素濃度計が組み込まれていない血液ガス分析装置は、PO とさまざまな境界から評価された SO2 を報告します。

現在の分析装置は、血液ガスパラメータだけでなく、電解質（PH、ナトリウム、カリウム、塩素、イオン化カルシウム、イオン化マグネシウム）と代謝物（グルコース、乳酸、ビリルビン、クレアチニン）も測定します。救急科および集中治療科では、患者の臨床状態を評価するための重要な手段として BGA を使用しています。

India Blood Gas Analyzer Market Dynamics

Drivers

• Rising prevalence of chronic disorders

The change in lifestyle habits, such as smoking tobacco, drinking liquor, having a stationary way of life, and numerous others, has raised the instances of patients experiencing constant ailment. The rising prevalence of chronic disorders is expected to boost market growth and positively influence the blood gas analyzer market.

• Increased number of patients treated in emergency care and intensive care units

The increased number of patients being treated in NICUs, emergency departments, and ICUs is rising with the increase in the number of chronic disorders, which is leading more patients into NICUs, emergency departments, and ICUs. The increased number of patients treated in emergency care and intensive care units will act as one of the major drivers in the growth of the India blood gas analyzer market.

• Increase in the number of product launches

Growing research activities to miniaturize the blood gas analyzer presents a great opportunity and a large number of product approval by market key players. The products perform multiple tests and provide coverage of wide results that will help in the rise of the blood analyzer market. The product portfolio for the companies working in this market is vast, and due to this, the revenue of the companies has increased continuously from the past recent revenue years. An increased number of product approval will act as a driver to boost the growth of the India blood gas analyzer market in the forecast period.

Opportunities

• Rising technological advancement in blood gas analyzer

Technological advancement plays an important role in almost all processes of the healthcare industry, such as the possibility of medication errors, which exist due to an increase in disease burden, patient registration for data management, and laboratory testing for self-care equipment. The reach of these technological innovations can be seen in healthcare with the development of technologies. The commercialization of advanced technology-based blood gas analyzers has increased its demand among consumers due to the increasing prevalence of chronic diseases, raising the need for the India blood gas analyzer market.

• Increasing initiatives by governmental bodies for diagnostic tools

Many governmental agencies and key market players in the blood gas analyzer market are involved in spreading the use and importance of devices among society and across the state. These initiatives by the market players and government are helping the users to reach out to take advantage of the policies made for low-income and developing states that make them aware of preventable diseases if diagnosed earlier. The growth of blood gas analyzer in hospitals and emergency rooms are strongly encouraged due to the increased prevalence of chronic diseases in the nation and rising initiatives by government bodies. Various government bodies are taking initiatives to extend healthcare facilities to remote regions, such as Ayushman Bharat Yojana and National Rural Health Mission among others. Increasing initiatives by the government bodies are acting as an opportunity for the growth of the India blood gas analyzer market.

Restraints/Challenges

• Lack of skilled professionals

The lack of capable laboratory professionals is not a new story in diagnosis and healthcare. As with the increase in the burden of chronic diseases, the increase in the aged population and the development of healthcare insurance have increased the demand for healthcare laboratory professionals. Another reason is the lack of training sessions for the professionals. Factors such as the retention rate and workload lack of certification are reasons for the lack of trained laboratory manpower, lack of education, and relevant degrees. These factors are hampering the growth of the India blood gas analyzer market.

• Lack of reimbursement policies for blood gas analyzer

Reimbursement for blood gas analyzer tests and services has been under downward pressure for several years. The blood gas analyzer also faces major roadblocks in its growth due to the lack of reimbursement for these services.

The reimbursement of a device can significantly affect the ability of a provider to access a particular technology, as well as the willingness of a manufacturer to deliver it. If coverage is uncertain, the manufacturer has difficulty predicting whether an investment in new technology will yield enough returns. This lack of predictability is an apparent barrier to obtaining funding for the company. It further compromises innovation and restricts patient access to advanced technology and solutions.

Thus, inadequate reimbursement coverage may act as a restraint to the growth of the market in the forecast period.

• High cost associated with parts of analyzers

The rise in the cost of the blood gas analyzers components is due to robust research and effectiveness. However, the price of the material used and the developments incurred in the therapeutics and services would increase the number of manufacturing units and more workforce and human resources required to diagnose and screen pathogen viability. The rise in the cost of blood gas analyzers is due to technological development and increased demand for non-invasive in hospitals, clinics, nursing facilities, and ambulatory surgical centers. Therefore, the present high cost is expected to show a descending trend in the future.

Post-COVID-19 Impact on India Blood Gas Analyzer Market

COVID-19 has positively affected the India blood gas analyzers market. Lockdowns and isolation during pandemics complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration will further affect the market.

Recent Development

• In September 2021, Sensacore announced the launch of ST-200 CC Blood Gas Analyzer-Ultra Smart is the highly advanced blood gas model of Sensacore. It is a completely automated, microprocessor-controlled electrolyte system that uses direct current measurement with ION selective electrode (ISE), Impedance (Hct), and Amperometry (pO2) technology to make arterial blood gas analysis and electrolyte measurements
• In September 2020, Agappe diagnostics Ltd. launched a new hematology analyzer- Mispa Count X. Mispa Count X with Smart Impedance Technology is an advanced 3-part differential cell counter which offers quality CBC testing to deliver safe patient care

The India Blood Gas Analyzer Market Scope

India blood gas analyzer market is categorized into five notable segments such as product type, modality, medical condition, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

BY PRODUCT TYPE

• Instruments
• Consumables

On the basis of product type, the India blood gas analyzer market is segmented into instruments and consumables.

 BY MODALITY

• Benchtop
• Portable
• Handheld

On the basis of modality, the India blood gas analyzers market is segmented into handheld, benchtop, and portable.

 BY MEDICAL CONDITION

• Kidney dysfunction
• Cardiovascular disorder
• Diabetes
• Hemorrhage
• Others

On the basis of medical condition, the India blood gas analyzers market is segmented into kidney dysfunction, cardiovascular disorder, diabetes, hemorrhage, and others.

BY DISTRIBUTION CHANNEL

• Direct tender
• Retail sale

On the basis of distribution channel, the India blood gas analyzers market is segmented into direct tender and retail sale distributors.

BY END USERS

• Hospital
• Clinical laboratories
• Research/Academic institute
• Home setting
• Others

エンドユーザーに基づいて、インドの血液ガス分析装置市場は、病院、臨床検査室、研究/学術機関、家庭環境、その他に分類されます。

インドの血液ガス分析装置市場の地域分析/洞察   

インドの血液ガス分析装置市場が分析され、製品タイプ、モダリティ、病状、エンドユーザー、流通チャネルから市場規模の洞察と傾向が提供されます。

レポートの国別セクションでは、市場の現在および将来の動向に影響を与える個別の市場影響要因と市場規制の変更についても説明しています。新規および交換販売、国の人口統計、疾病疫学、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。さらに、アジア太平洋ブランドの存在と可用性、地元および国内ブランドとの激しい競争によって直面する課題、販売チャネルの影響を考慮しながら、国別データの予測分析を提供します。

競争環境と血液ガス分析装置の市場シェア分析

インドの血液ガス分析装置市場の競争状況は、競合他社による詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、インドでのプレゼンス、生産拠点と施設、生産能力、会社の長所と短所、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、インドの血液ガス分析装置市場への会社の焦点にのみ関連しています。

この市場で取引を行っている大手企業としては、Abbott、Techno MedicaCo., Ltd.、Nova Biomedical、WERFEN、Sensacore、OPTI Medical Systems、HDC India、AFFORD MEDICAL TECHNOLOGIES PVT. LTD.、Radiometer India（Danaher の子会社）、Siemens Healthcare Private Limited（Siemens の子会社）、F. Hoffmann-La Roche Ltd.、i-SENS、Inc.、EDAN Instruments、Inc.、ESCHWEILER GmbH & CO.KG、essential medical、Medica Corporation、Wondfo などがあります。

SKU-69550